DJIA 17,079.57 -42.44 -0.25%
NASDAQ 4,557.70 -11.93 -0.26%
S&P 500 1,996.74 -3.38 -0.17%
market minute promo

Novartis (NYSE: NVS)

89.73 -0.27 (-0.30%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVS $89.73 -0.30%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $89.29
Previous Close $90.00
Daily Range $89.20 - $89.87
52-Week Range $72.24 - $91.66
Market Cap $217.7B
P/E Ratio 24.32
Dividend (Yield) $2.72 (2.6%)
Ex-Dividend Date
Dividend Pay Date
02/27/14
04/10/14
Volume 1,240,221
Average Daily Volume 1,027,229
Current FY EPS $5.19

Sector

Healthcare

Industry

Drugs

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/

News & Commentary Rss Feed

3 Reasons Pfizer Inc.'s Stock Could Fall

Despite rumors about mergers and acquisitions, these three catalysts could wind up pressuring Pfizer's stock and ultimately pushing it lower.

I Am Sure This Pharma-Company Suits Your Portfolio

Alkermes Gains on Aripiprazole Lauroxil NDA Submission - Analyst Blog

Heating up: Burger King is latest in M&A frenzy

Apricus Biosciences: A Screaming Buy Or A Falling Knife?

Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 22, 2014

Pre-Market Activity Shows Heavy Volume And Movement For Novartis (NVS)

Pre-Market Most Active for Aug 21, 2014 : NVS, BAC, MCC, HTZ, DG, JRJC, NOK, AAPL, QQQ, DLTR, FB, T

Pre-Market Most Active for Aug 21, 2014 : NVS, BAC, MCC, HTZ, DG, JRJC, NOK, AAPL, QQQ, DLTR, FB, TVIX

Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog

Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog

Apricus Biosciences' ED Treatment Vitaros Now in Germany - Analyst Blog

See More NVS News...

NVS's Top Competitors

NVS $89.73 (-0.30%)
Current stock: NVS
JNJ $102.95 (-0.26%)
Current stock: JNJ
PFE $29.38 (-0.37%)
Current stock: PFE
GSK $48.87 (0.41%)
Current stock: GSK